GenomicsbioRxivPreprint
Integrative genomic, transcriptomic, and epigenomic analyses of benign prostatic hyperplasia reveal new options for therapy
Deli Liu, Jonathan Evan Shoag, Daniel Poliak…·Christopher E. Barbieri
This study identifies molecular subgroups of BPH and suggests mTOR inhibitors as a potential therapy for specific subtypes.
DOI 10.1101/805168